Candano, Baby Boy .
HRN: 24-20-03 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/15/2023
MUPIROCIN 2%, 15G (TUBE)
12/15/2023
12/22/2023
TOPICAL
Topical
Bid
Phlebitis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes